Xencor (XNCR) Short term Debt (2023 - 2026)
Xencor's (XNCR) quarterly Short term Debt came in at $26.4 million in Q1 2026, down 49.74% year-on-year from $52.5 million in Q1 2025, and down 38.96% on a QoQ basis from $43.3 million in Q4 2025.
Xencor (XNCR) Short term Debt (2023 - 2026) Analysis & Trends
Xencor (XNCR) has 4 years of Short term Debt data on file, last reported at $26.4 million in Q1 2026.
- On a quarterly basis, Short term Debt fell 49.74% year-over-year to $26.4 million in Q1 2026; TTM through Mar 2026 was $26.4 million, a 49.74% decrease from a year earlier, with the FY2025 full-year figure at $43.3 million, down 10.69% from the prior year.
- Short term Debt for Q1 2026 stood at $26.4 million, down from $43.3 million in the prior quarter.
- Over the last five years, Short term Debt for XNCR reached as high as $52.5 million in Q1 2025 and fell as low as $26.4 million in Q1 2026.
- Historically, Short term Debt has averaged $41.2 million across 4 years, with a median of $43.9 million in 2024.
- Across the five-year window, Short term Debt surged 74.83% in 2024 and sank 49.74% in 2026, its largest moves.
- Year by year, Short term Debt stood at $27.7 million in 2023, then jumped by 74.83% to $48.4 million in 2024, then dropped by 10.69% to $43.3 million in 2025, then sank by 38.96% to $26.4 million in 2026.
- Per Business Quant data, the three most recent Short term Debt figures were $26.4 million in Q1 2026, $43.3 million in Q4 2025, and $45.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Xencor | 1.47 Bn | 1.09 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.41 Mn |
| Dec 31, 2025 | 43.27 Mn |
| Sep 30, 2025 | 45.36 Mn |
| Jun 30, 2025 | 50.29 Mn |
| Mar 31, 2025 | 52.54 Mn |
| Dec 31, 2024 | 48.45 Mn |
| Sep 30, 2024 | 44.46 Mn |
| Jun 30, 2024 | 38.93 Mn |
| Mar 31, 2024 | 34.20 Mn |
| Dec 31, 2023 | 27.71 Mn |